Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.651, 2012-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Canada funds denosumab, telaprevir and rivaroxaban
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 653, 2012-01 ,pp. :
Access to resources
Recommend
NICE offers a second look at denosumab . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :
NICE gives thumbs up to rivaroxaban
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 655, 2012-01 ,pp. :
NICE wants more info on rivaroxaban for AF . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :
NICE recommendations submitted by Kennedy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 584, 2009-01 ,pp. :